D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 29,713 419 World Ranking 7654 National Ranking 4132

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Radiation therapy

The scientist’s investigation covers issues in Radiation therapy, Prostate cancer, Nuclear medicine, Oncology and Internal medicine. His Radiation therapy study incorporates themes from Prostatectomy, Prostate and Urology. Mack Roach has researched Prostate cancer in several fields, including Clinical trial and Toxicity.

His research in Nuclear medicine intersects with topics in Gold marker, Radiation treatment planning, Rectum, Fiducial marker and Carcinoma. He has included themes like Localized disease, Survival analysis, Chemotherapy and Disease in his Oncology study. His work in the fields of Internal medicine, such as Cancer, intersects with other areas such as Risk assessment.

His most cited work include:

  • Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference (1831 citations)
  • Prostate cancer. Clinical practice guidelines in oncology. (870 citations)
  • Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases (588 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Prostate cancer, Radiation therapy, Internal medicine, Oncology and Prostate. His biological study spans a wide range of topics, including Radiology and Brachytherapy. His biological study deals with issues like Hormonal therapy, which deal with fields such as Androgen suppression.

His work carried out in the field of Oncology brings together such families of science as Androgen, Survival analysis, Disease and Goserelin. His research integrates issues of Radiation treatment planning, Rectum, Nuclear medicine, Magnetic resonance imaging and Stage in his study of Prostate. His Nuclear medicine research incorporates themes from Dose fractionation and Planning target volume.

He most often published in these fields:

  • Prostate cancer (65.29%)
  • Radiation therapy (52.41%)
  • Internal medicine (43.22%)

What were the highlights of his more recent work (between 2014-2021)?

  • Prostate cancer (65.29%)
  • Internal medicine (43.22%)
  • Oncology (40.92%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Radiology. His work deals with themes such as Randomized controlled trial, Prostate and Brachytherapy, which intersect with Prostate cancer. Mack Roach focuses mostly in the field of Prostate, narrowing it down to topics relating to Nuclear medicine and, in certain cases, Genitourinary system and Common Terminology Criteria for Adverse Events.

The various areas that Mack Roach examines in his Oncology study include Toxicity, Phases of clinical research, Meta-analysis, Disease and Hormonal therapy. Radiation therapy is a subfield of Surgery that Mack Roach tackles. His research in Radiology intersects with topics in Systematic review and Contrast.

Between 2014 and 2021, his most popular works were:

  • Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology (544 citations)
  • Prostate Cancer, Version 1.2016 (441 citations)
  • Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 (333 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiation therapy

Mack Roach mainly investigates Prostate cancer, Internal medicine, Radiation therapy, Oncology and Clinical trial. The Prostate cancer study combines topics in areas such as Prostate, Radiology and Brachytherapy. His Prostate research includes elements of Nuclear medicine and Urology.

His Radiation therapy research is within the category of Surgery. His Oncology research integrates issues from Consensus conference, Disease, Evidence-based medicine, Hormone sensitive prostate cancer and Hormonal therapy. His Clinical trial research incorporates elements of Cancer, Cancer registry, Medical physics and Patient participation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach;Gerald Hanks;Howard Thames;Paul Schellhammer.
International Journal of Radiation Oncology Biology Physics (2006)

3213 Citations

Prostate cancer. Clinical practice guidelines in oncology.

James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby.
Journal of The National Comprehensive Cancer Network (2010)

1273 Citations

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

James L. Mohler;Emmanuel S. Antonarakis;Andrew J. Armstrong;Anthony V. D'Amico.
Journal of The National Comprehensive Cancer Network (2019)

972 Citations

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

William F. Harstell;Charles B. Scott;Deborah Watkins Bruner;Charles W. Scarantino.
Journal of the National Cancer Institute (2005)

862 Citations

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

Mack Roach;Kyounghwa Bae;Joycelyn Speight;Harvey B. Wolkov.
Journal of Clinical Oncology (2008)

830 Citations

Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.

Mack Roach;M. DeSilvio;C. Lawton;V. Uhl.
Journal of Clinical Oncology (2003)

710 Citations

Prostate Cancer, Version 1.2016

James L. Mohler;Andrew J. Armstrong;Robert R. Bahnson;Anthony Victor D'Amico.
Journal of The National Comprehensive Cancer Network (2016)

651 Citations

An Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG 94-13, With Emphasis on Unexpected Hormone/Radiation Interactions

Colleen A. Lawton;Michelle DeSilvio;Mack Roach;Valery Uhl.
International Journal of Radiation Oncology Biology Physics (2007)

600 Citations

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

Peter Grimm;Ignace Billiet;David Bostwick;Adam P Dicker.
BJUI (2012)

576 Citations

Low-dose megavoltage cone-beam CT for radiation therapy.

Jean Pouliot;Ali Bani-Hashemi;Josephine Chen;Michelle Svatos.
International Journal of Radiation Oncology Biology Physics (2005)

513 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mack Roach

Anthony V. D'Amico

Anthony V. D'Amico

Brigham and Women's Hospital

Publications: 145

Paul L. Nguyen

Paul L. Nguyen

Harvard Medical School

Publications: 141

Michael J. Zelefsky

Michael J. Zelefsky

Memorial Sloan Kettering Cancer Center

Publications: 112

Howard M. Sandler

Howard M. Sandler

Cedars-Sinai Medical Center

Publications: 111

Eric M. Horwitz

Eric M. Horwitz

Fox Chase Cancer Center

Publications: 93

Alan Pollack

Alan Pollack

University of Miami

Publications: 89

Stephen J. Freedland

Stephen J. Freedland

Cedars-Sinai Medical Center

Publications: 88

David P. Dearnaley

David P. Dearnaley

Institute of Cancer Research

Publications: 84

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 83

Patrick A. Kupelian

Patrick A. Kupelian

University of California, Los Angeles

Publications: 79

Matthew R. Cooperberg

Matthew R. Cooperberg

University of California, San Francisco

Publications: 78

R. Jeffrey Karnes

R. Jeffrey Karnes

Mayo Clinic

Publications: 77

Peter R. Carroll

Peter R. Carroll

University of California, San Francisco

Publications: 76

Deborah A. Kuban

Deborah A. Kuban

The University of Texas MD Anderson Cancer Center

Publications: 75

Richard G. Stock

Richard G. Stock

Icahn School of Medicine at Mount Sinai

Publications: 74

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 68

Trending Scientists

Ralph E. Johnson

Ralph E. Johnson

University of Illinois at Urbana-Champaign

Richard L. Church

Richard L. Church

University of California, Santa Barbara

Qing Shen

Qing Shen

University of Electro-Communications

David J. Rawlings

David J. Rawlings

Seattle Children's Hospital

Ian D. Hodkinson

Ian D. Hodkinson

Liverpool John Moores University

Chris Bass

Chris Bass

University of Exeter

Christian Klein

Christian Klein

Roche (Switzerland)

Susana Alvarez

Susana Alvarez

National Scientific and Technical Research Council

Göstar Klingelhöfer

Göstar Klingelhöfer

Johannes Gutenberg University of Mainz

Dirk H. Busch

Dirk H. Busch

Technical University of Munich

Adrian Liston

Adrian Liston

Babraham Institute

Laurence M. Binder

Laurence M. Binder

Oregon Health & Science University

Russell K. Portenoy

Russell K. Portenoy

Albert Einstein College of Medicine

Claus G. Roehrborn

Claus G. Roehrborn

The University of Texas Southwestern Medical Center

Karen P. Alexander

Karen P. Alexander

Duke University

Michael Siegel

Michael Siegel

Tufts University

Something went wrong. Please try again later.